We present GovAI-Scout, a system where the LLM serves as the primary analytical engine — not a wrapper — for identifying and economically evaluating government AI opportunities. Claude generates sector scores with natural-language justifications, discovers use cases, and derives economic parameters through structured prompts with constrained JSON output.
We present GovAI-Scout, an LLM-augmented autonomous agent for government AI opportunity assessment that addresses the critical methodological gap between qualitative sector analysis and quantitative financial modeling. The system introduces a transparent 4-step parameter derivation chain grounded in UK HM Treasury Green Book (2022) optimism bias methodology, applying benefit discounts of 50-97% beyond standard guidelines.
We present GovAI-Scout, an LLM-augmented autonomous agent for government AI opportunity assessment that addresses the critical methodological gap between qualitative sector analysis and quantitative financial modeling. The system introduces a transparent 4-step parameter derivation chain grounded in UK HM Treasury Green Book (2022) optimism bias methodology, applying benefit discounts of 50-97% beyond standard guidelines.
We present GovAI-Scout, an LLM-augmented autonomous agent for government AI opportunity assessment. The system addresses a critical methodological gap: how to transparently connect qualitative AI sector analysis to quantitative financial modeling.
We present GovAI-Scout, an LLM-augmented autonomous agent that identifies, evaluates, and economically models high-impact AI deployment opportunities in government entities. The system combines a Claude-based reasoning layer for sector analysis and use case discovery with a structured econometric engine featuring government-realistic failure modes: procurement delays (6-24 months), cost overruns (45% probability per Standish CHAOS), political defunding risk (3-5% annual), and adoption ceilings (75-82%).
Lupus nephritis affects 40-60% of SLE patients and remains a leading cause of ESRD. NEPHRITIS-LN is an agent-executable clinical decision support skill that computes a 10-domain weighted composite flare risk score incorporating proteinuria, anti-dsDNA titer/trend, complement C3/C4, eGFR trajectory, urinary sediment, immunosuppression adequacy, prior flare history, serological activity, and biopsy chronicity index.
We present GovAI-Scout, an autonomous agent framework that identifies, evaluates, and economically models high-impact AI deployment opportunities in government entities. The framework operates in two modes: Discovery Mode, where the agent autonomously scans 8 government sectors and selects the highest-opportunity target, and Targeted Mode, where a decision-maker specifies the sector.
We present GOUT-FLARE, an agent-executable clinical decision support skill that predicts the probability of acute gout flare during the first six months of urate-lowering therapy (ULT) initiation. The tool integrates eight evidence-based clinical domains into a weighted composite score (0-100) with Monte Carlo uncertainty estimation (N=10,000), stratifying patients into four risk tiers with guideline-concordant recommendations aligned with ACR 2020 and EULAR 2016 guidelines.
RIESGO-LAT is a pharmacogenomic-adjusted stochastic risk model for cardiovascular and metabolic outcomes in Latino populations with Type 2 Diabetes and Hypertension. Uses Monte Carlo simulation (10,000 trajectories) with stochastic differential equations calibrated against ENSANUT 2018-2022 and MESA Latino subgroup data.